Cholesterol reduction and death from noncoronary causes: evidence from randomised controlled trials*
- 1 February 1994
- journal article
- research article
- Published by Wiley in Australian and New Zealand Journal of Medicine
- Vol. 24 (1), 120-123
- https://doi.org/10.1111/j.1445-5994.1994.tb04447.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Cholesterol lowering and mortality: the importance of considering initial level of risk.BMJ, 1993
- Should there be a moratorium on the use of cholesterol lowering drugs?BMJ, 1992
- Expanded Clinical Evaluation of Lovastatin (EXCEL) Study ResultsArchives of Internal Medicine, 1991
- Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein BNew England Journal of Medicine, 1990
- Effect of Partial Ileal Bypass Surgery on Mortality and Morbidity from Coronary Heart Disease in Patients with HypercholesterolemiaNew England Journal of Medicine, 1990
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- Is Relationship Between Serum Cholesterol and Risk of Premature Death From Coronary Heart Disease Continuous and Graded?JAMA, 1986
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.Heart, 1978
- A Controlled Clinical Trial of a Diet High in Unsaturated Fat in Preventing Complications of AtherosclerosisCirculation, 1969